Membrane Protein Bioreagents, Gene-to-Protein CRO, Genetic Diagnostics
Mountain View, CA
Joined January 2013
- Tweets602
- Following656
- Followers319
- Likes201
ProNovus Bioscience retweeted
And for more on applications of machine learning in drug discovery and development, here's a recent review go.nature.com/2GgbGuK
ProNovus Bioscience retweeted
Just had coffee with a friend and biotech CEO. They’re moving operations out of the Bay Area and California entirely, decamping for sites back East, eg RTP.
It’s gotten to the point where you have to be a Pharma or enjoy setting cash on fire to operate a lab in the Bay Area.
ProNovus Bioscience retweeted
Gene Hackers: The Young #Biotech #Entrepreneurs Looking To Make Billions By Editing Life Itself bit.ly/2Q3Vnok @ellie_kincaid @mtindera07 #geneediting #genomeediting #CRISPR #synbio @CaribouBio @eGenesisBio @mammothbiosci
ProNovus Bioscience retweeted
#Biotech companies raised $16.8 billion in #venturecapital in 2018 compared to $12.1 billion in 2017. Additionally, the average amount per round of financing was 42 percent more than in 2017.
fiercebiotech.com/special-re…
ProNovus Bioscience retweeted
New computational tool enables powerful molecular analysis of biomedical tissue samples rna-seqblog.com/new-computat…
The trickster microbes that are shaking up the tree of life, from @nature
nature.com/articles/d41586-0…
ProNovus Bioscience retweeted
Fascinating paper on changes in levels of mGlu5 in PTSD linked to suicidal thoughts. Potential biomarker and pathway for treatment. pnas.org/content/early/2019/…
ProNovus Bioscience retweeted
Fierce competition among biosimilar manufacturers in China, India and South Korea means they are outcompting Western biosimilar manufacturers in low-income markets go.nature.com/2PWYnmd
ProNovus Bioscience retweeted
Antibiotic mechanisms are revealed by a white-box machine-learning approach that integrates biochemical screening and metabolic network modeling. #NBThighlight bit.ly/2HcX4eV
ProNovus Bioscience retweeted
These 6 biotech stocks are promising takeover targets dlvr.it/R3xjly
ProNovus Bioscience retweeted
.@NIH is seeking public comments on future plans for the #BRAINInitiative. Submit your input here: bit.ly/2Gl6fK5 #studyBRAIN
ProNovus Bioscience retweeted
Great review on tractability of allosteric binding sites on GPCRs informed by x-ray structures ncbi.nlm.nih.gov/pubmed/3099…
ProNovus Bioscience retweeted
“Everyone agrees that there is an absolute need for new antibiotics but there is no sustainable market,” @IFPMA’s Thomas Cueni warns on the growing threat of antimicrobial resistance. buff.ly/2LeTpmf
ProNovus Bioscience retweeted
.@deevybee urges researchers to rein in the four horsemen of the reproducibility apocalypse: publication bias, low statistical power, P-value hacking and HARKing. go.nature.com/2L0zWpr
ProNovus Bioscience retweeted
Two new studies report the first cryo-EM structures of a GABAA receptor in a physiological conformation and in complex with various drugs. These structures could provide the basis for future structure-based drug discovery. go.nature.com/2QD9wY7 @RaduAricescu and @MRC_LMB
ProNovus Bioscience retweeted
Researchers develop a method to investigate how bacteria respond to starvation and to identify which proteins bind to the “magic spot” — ppGpp. Explore in 3D at RCSB PDB: rcsb.org/structure/6CZF
news.mit.edu/2018/mit-biolog…
ProNovus Bioscience retweeted
Advanced biomaterials and drug delivery systems could improve the potency of cancer immunotherapies while reducing toxicities - find out more in this new review by Rachel Riley, Carl June, Robert Langer and Michael Mitchell go.nature.com/2TG3c4f
ProNovus Bioscience retweeted
human TP bound to two antagonists, ramatroban and daltroban
nature.com/articles/s41589-0…
human EP3 bound to misoprostol-FA
nature.com/articles/s41589-0…
human EP3 bound to endogenous ligand PGE2
nature.com/articles/s41589-0…
今週のNCBはclass A GPCRの新規構造祭り。
